Run-time resource allocation for embedded Multiprocessor System-on-Chip using tree-based design space exploration

The dynamic nature of application workloads in modern MPSoC-based embedded systems is growing. To cope with the dynamism of application workloads at run time and to improve the efficiency of the underlying system architecture, this paper presents a novel run-time resource allocation algorithm for multimedia applications with the objective of minimizing energy consumption for predefined deadlines. This algorithm is based on a novel tree-based design space exploration (DSE) method, which is performed in two phases: design-time and run-time. During design time, application clustering is combined with the tree-based DSE, and after that, feature extraction and application classification is performed during run-time based on well-known machine learning techniques. We evaluated our algorithm using a heterogeneous MPSoC system with several applications that have different communication and computation behaviors. Our experimental results revealed that during runtime, more than 91% of the applications were classified correctly by our proposed algorithm to select the best resources for allocation. Therefore the results clearly confirm that our algorithm is effective

Evaluation of metallothionein protein as a biomarker of Mercury pollution in Scat (Scatophagus argus)

Total Metallothionein (MT) biosynthesis and Mercury bioaccumulation under control & acute Mercury exposure were investigated in Scat (Scatophagus argus). Tissues from liver and gill of samples Scats were exposed to different Mercury concentrations (10, 20, 30μ g/l) for 24, 48, 72 hours. Mercury contents were determined through Cold Vapour Atomic Absorption Spectrometry (CVAAS). Total MT levels were determined by Enzyme-linked Immunosorbent Assay (ELISA) method. Induction of MT during exposure was tissue specific, displaying different response patterns in gill and liver. Mercury accumulated in liver much stronger than gill and the latter also showed lower MT level. Although after exposure to different mercury concentration during different periods, MT biosynthesis in liver showed a significant increase (P<0.05) but in gill did not significantly modify total MT except for 72h exposure at 30 g/l. Nonetheless, the relationship between MT biosynthesis and Mercury bioaccumulation in both tissues was significant. The results suggest that this form of MT presence in S. argus was Hg-inducible and could be extended as a biomarker of Mercury pollution in marine ecosystems and especially in Persian Gulf

Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019

Background The causes for immune-mediated inflammatory diseases (IMIDs) are diverse and the incidence trends of IMIDs from specific causes are rarely studied. The study aims to investigate the pattern and trend of IMIDs from 1990 to 2019. Methods We collected detailed information on six major causes of IMIDs, including asthma, inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, psoriasis, and atopic dermatitis, between 1990 and 2019, derived from the Global Burden of Disease study in 2019. The average annual percent change (AAPC) in number of incidents and age standardized incidence rate (ASR) on IMIDs, by sex, age, region, and causes, were calculated to quantify the temporal trends. Findings In 2019, rheumatoid arthritis, atopic dermatitis, asthma, multiple sclerosis, psoriasis, inflammatory bowel disease accounted 1.59%, 36.17%, 54.71%, 0.09%, 6.84%, 0.60% of overall new IMIDs cases, respectively. The ASR of IMIDs showed substantial regional and global variation with the highest in High SDI region, High-income North America, and United States of America. Throughout human lifespan, the age distribution of incident cases from six IMIDs was quite different. Globally, incident cases of IMIDs increased with an AAPC of 0.68 and the ASR decreased with an AAPC of −0.34 from 1990 to 2019. The incident cases increased across six IMIDs, the ASR of rheumatoid arthritis increased (0.21, 95% CI 0.18, 0.25), while the ASR of asthma (AAPC = −0.41), inflammatory bowel disease (AAPC = −0.72), multiple sclerosis (AAPC = −0.26), psoriasis (AAPC = −0.77), and atopic dermatitis (AAPC = −0.15) decreased. The ASR of overall and six individual IMID increased with SDI at regional and global level. Countries with higher ASR in 1990 experienced a more rapid decrease in ASR. Interpretation The incidence patterns of IMIDs varied considerably across the world. Innovative prevention and integrative management strategy are urgently needed to mitigate the increasing ASR of rheumatoid arthritis and upsurging new cases of other five IMIDs, respectively. Funding The Global Burden of Disease Study is funded by the Bill and Melinda Gates Foundation. The project funded by Scientific Research Fund of Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (2022QN38)

Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

Background Rheumatoid arthritis is a chronic autoimmune inflammatory disease associated with disability and premature death. Up-to-date estimates of the burden of rheumatoid arthritis are required for health-care planning, resource allocation, and prevention. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, we provide updated estimates of the prevalence of rheumatoid arthritis and its associated deaths and disability-adjusted life-years (DALYs) by age, sex, year, and location, with forecasted prevalence to 2050. Methods Rheumatoid arthritis prevalence was estimated in 204 countries and territories from 1990 to 2020 using Bayesian meta-regression models and data from population-based studies and medical claims data (98 prevalence and 25 incidence studies). Mortality was estimated from vital registration data with the Cause of Death Ensemble model (CODEm). Years of life lost (YLL) were calculated with use of standard GBD lifetables, and years lived with disability (YLDs) were estimated from prevalence, a meta-analysed distribution of rheumatoid arthritis severity, and disability weights. DALYs were calculated by summing YLLs and YLDs. Smoking was the only risk factor analysed. Rheumatoid arthritis prevalence was forecast to 2050 by logistic regression with Socio-Demographic Index as a predictor, then multiplying by projected population estimates. Findings In 2020, an estimated 17·6 million (95% uncertainty interval 15·8–20·3) people had rheumatoid arthritis worldwide. The age-standardised global prevalence rate was 208·8 cases (186·8–241·1) per 100 000 population, representing a 14·1% (12·7–15·4) increase since 1990. Prevalence was higher in females (age-standardised female-to-male prevalence ratio 2·45 [2·40–2·47]). The age-standardised death rate was 0·47 (0·41–0·54) per 100 000 population (38 300 global deaths [33 500–44 000]), a 23·8% (17·5–29·3) decrease from 1990 to 2020. The 2020 DALY count was 3 060 000 (2 320 000–3 860 000), with an age-standardised DALY rate of 36·4 (27·6–45·9) per 100 000 population. YLDs accounted for 76·4% (68·3–81·0) of DALYs. Smoking risk attribution for rheumatoid arthritis DALYs was 7·1% (3·6–10·3). We forecast that 31·7 million (25·8–39·0) individuals will be living with rheumatoid arthritis worldwide by 2050. Interpretation Rheumatoid arthritis mortality has decreased globally over the past three decades. Global age-standardised prevalence rate and YLDs have increased over the same period, and the number of cases is projected to continue to increase to the year 2050. Improved access to early diagnosis and treatment of rheumatoid arthritis globally is required to reduce the future burden of the disease. Funding Bill & Melinda Gates Foundation, Institute of Bone and Joint Research, and Global Alliance for Musculoskeletal Health

Why COVID-19 is less frequent and severe in children: a narrative review

Background: Despite the streaks of severity, severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection is, in general, less frequent and severe in children than in adults. We searched for causal evidence of this mystery. Data sources: An extensive search strategy was designed to identify papers on coronavirus disease 2019 (COVID-19). We searched Ovid MEDLINE, PubMed, EMBASE databases, and Cochrane library and carried out a review on the causes of this dilemma. Results: Our searches produced 81 relevant articles. The review showed that children accounted for a lower percentage of reported cases, and they also experienced less severe illness courses. Some potential explanations, including the tendency to engage the upper airway, the different expression in both receptors of angiotensin-converting enzyme and renin�angiotensin system, a less vigorous immune response, the lower levels of interleukin (IL)-6, IL-10, myeloperoxidase, and P-selectin and a higher intracellular adhesion molecule-1, a potential protective role of lymphocytes, and also lung infiltrations might have protective roles in the immune system�respiratory tract interactions. Finally, what have shed light on this under representation comes from two studies that revealed high-titer immunoglobulin-G antibodies against respiratory syncytial virus and mycoplasma pneumonia, may carry out cross-protection against SARS-CoV-2 infection, just like what suggested about the vaccines. Conclusions: These results require an in-depth look. Properties of the immune system including a less vigorous adaptive system beside a preliminary potent innate response and a trained immunity alongside a healthier respiratory system, and their interactions, might protect children against SARS-CoV-2 infection. However, further studies are needed to explore other possible causes of this enigma. © 2020, Children's Hospital, Zhejiang University School of Medicine

Run-time Mapping Algorithm for Dynamic Workloads using Process Merging Transformations

Exploration of task mappings has an important role to achieve high performance in heterogeneous multi-processor system-on-chip (MPSoC) platforms. The application workloads in modern MPSoC-based embedded systems are becoming increasingly dynamic. Different applications concurrently execute and contend for resources in such systems. In this paper, a run-time algorithm is proposed to analytically evaluate the system throughput of to-be-executed applications (modelled as Kahn Process Networks, KPNs) in order to quickly determine a proper resource binding for these applications. Merging transformations on the KPNs are applied to capture the cases in which the number of processes in the KPN is larger than the number of available processing resources, thereby modeling the effects of binding multiple processes to a single processor. We evaluated our algorithm using a heterogeneous MPSoC system with several applications. Our experimental results revealed that during runtime, the performance of selected mapping with regard to available resources is close to the optimal performance obtained by exhaustive search and simulation. Therefore, the results clearly confirm that our algorithm is effective